Thank you, Mr. Chairman.
Welcome to representatives of the PMPRB.
From your description of your activity level and the budgetary reflection of that, may I say that I welcome what I sense to be a more aggressive and activity-oriented stance from the last few times we've had your organization in front of us.
I'm wondering about the source of these eight notices of hearings and 33 ongoing investigations. Are you getting complaints from the public, from pharmacists, from doctors, or from provinces that run drug plans, or is it simply the time in the history of the board when it is looking inward and reflecting on whether it's being aggressive enough?